Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here


 

Repligen to buy back up to 1.25 million common shares

Wednesday, June 18, 2008; Posted: 07:29 AM
Stocks RSS
7 Stocks You Need To Know For Tomorrow -- Free Newsletter
BOSTON, Jun 18, 2008 (Thomson Financial via COMTEX) -- RGEN | Quote | Chart | News | PowerRating -- Repligen Corp. said Wednesday that its board approved the repurchase of up to 1.25 million shares of its common stock.

The company currently has 31.2 million shares outstanding and the stock repurchases will be funded through available cash.

Shares of the Waltham, Mass.-based therapeutics developer closed Tuesday at $4.75.

Greg Saulnier gs/pc

COPYRIGHT

Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

MMMM

For full details for RGEN click here.
Morning Coffee with TradingMarkets -- Free Newsletter

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.